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Abstract The mouse serotonin (5-HT) receptor subtype, 5-
HT7, belongs to the family of seven transmembrane G-protein-
coupled receptors. To identify the structural basis for the 
coupling of 5-HT7 receptor to Gas we constructed a number 
of receptor mutants in which amino acid residues were either 
substituted or deleted from the second and third intracellular 
loops. Wild-type and mutant 5-HT7 receptors were expressed in 
insect cells using the baculovirus vectors. Two mutant receptor 
species, 5-HT7(E325G) and 5-HT7(K327S), demonstrated 
markedly impaired abilities to stimulate adenylyl cyclase. The 
results suggest the importance of the C-terminal region of the 
third intracellular loop in receptor-G-protein interaction and 
that specific charged residues, E325 and K327, may play a 
critical role in this interaction. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
A large number of receptors belong to the family of seven 
t ransmembrane (7TM) receptors which are coupled to their 
intracellular effectors via guanine nucleotide binding proteins 
(G-proteins). These receptors are believed to share a common 
membrane topology consisting of seven a-helical membrane-
spanning segments connected by alternating extracellular and 
intracellular loops. The best characterised 7TM domain G-
protein-coupled receptor is the (3-adrenergic receptor [1]. Mu-
tational analysis of this receptor and other G-protein-coupled 
receptors has shown that a ligand binding pocket is formed by 
the 7TM spanning domains, while the amino acid sequences 
within the intracellular loops are involved in functional cou-
pling of the receptor to G-proteins [1,2]. The 13 different 
mammalian receptors which bind the biogenic amine seroto-
nin (5-hydroxytryptamine, 5-HT), also belong to the super-
family of 7TM domain G-protein-coupled receptors, with 
the exception of the 5-HT3 receptor which forms a serotonin 
gated ion channel [3]. Four 5-HT7 receptor subtypes have 
been identified by cloning from the following mammalian spe-
cies; mouse [4], rat [5-8], human [9] and guinea pig [10]. When 
expressed in cultured mammalian cell lines these receptors 
were found to stimulate adenylyl cyclase via the stimulatory 
G-protein, G a s . In this study we were interested in defining 
which regions of the mouse 5-HT7 receptor were critical for 
the interaction with Gag . To address this question we used 
the wealth of information available on the (52 adrenergic re-
ceptor (P2-AR) [1,2]. Studies on this receptor have shown that 
several amino acids in the second intracellular loop, and both 
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the amino (N)-terminal and carboxyl (C)-terminal regions of 
the third intracellular loop are required for the interaction 
with G a s [1,2]. We generated six mutan t 5-HT7 receptors 
which contained mutat ions within the second intracellular 
loop and in the N - and C-terminal portions of the third intra-
cellular loop of this receptor. Mutan t 5-HT7 receptors were 
expressed in Spodoptera frugiperda (Sf9) cells using baculo-
virus expression vectors, and were initially examined for their 
ability to bind both antagonist and agonist ligands. Two mu-
tant receptors, 5-HT7 (E325G) and 5-HT7 (K327S) which not 
only had comparable expression levels to that of the wild-type 
receptor but also displayed similar affinities for agonist and 
antagonist ligands were identified. More significantly, these 
mutan t receptors exhibited a marked impairment in ability 
to stimulate adenylyl cyclase when compared to the wild-
type receptor. The data presented here suggests a functional 
role for the C-terminal port ion of the third intracellular loop 
of the mouse 5-HT7 in receptor coupling to G a s and that this 
interaction may involve charged residues present in this do-
main. 
2. Materials and methods 
2.1. Expression vector construction and mutagenesis procedures 
The plasmid p514/5-HT7 containing a 1539 bp cDNA fragment 
encoding the wild-type mouse 5-HT7 receptor was subjected to the 
polymerase chain reaction (PCR) amplification technique using oligo-
nucleotide primers designed to amplify the coding region of the 5-HT7 
cDNA. PCR amplifications were performed using the high-fidelity Pfu 
DNA polymerase (Stratagene) and the resultant 1355 bp reaction 
product was cleaved with EcoRl and cloned into the baculovirus 
transfer vector pAcAL3 [11]. The authenticity of the DNA fragment 
was confirmed by double-stranded dideoxynuleotide sequencing. 
Mutant 5-HT7 receptors were generated by overlap extension PCR 
essentially as described by [12] except that reactions were performed 
with Pfu DNA polymerase. The correct identity of each DNA se-
quence was confirmed by double-stranded dideoxynuleotide sequenc-
ing. To construct the deletion mutant 5-HT7(A263-275), PCR prod-
ucts were obtained using the following sets primers: (a) 5'-
CGCGGATCCACGATGATGGACGTT-3 75' -GTACATGAACAG-
CATGAC-3' (b) 5'-CACAAGTTCTCAGGCTTC-375'-TTTGAAT-
TCATCATGTATCATGACCTT-3'. Products (a) and (b) were re-
stricted with the enzymes BamKI and EcoiR.1, respectively, and a 
three-component ligation was performed consisting of products (a) 
and (b) and the plasmid vector. Following, double-stranded DNA 
sequencing to verify the location of the junction site and to ensure 
that additional mutations had not been introduced, the DNA frag-
ment was subsequently ligated into the baculovirus transfer vector 
pAcAL3 [11]. 
2.2. Production of recomhinant baculoviruses 
All procedures for cell culture, identification and amplification of 
recombinant viruses were as detailed [11]. Recombinant viruses were 
produced by co-transfection of Sf21 cells with linearized BacPAK6 
DNA [13] and the appropriate transfer vector, using lipofectin (Gibco 
Life Technologies). For routine experiments, Sf9 cells cultured in se-
rum-free media (Sf900II, Gibco Life Technologies) were used. 
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2.3. Receptor binding assays 
Virus-infected Sf9 cells were harvested at 48 hpi and used to pre-
pare membranes as previously described [14]. For saturation experi-
ments, membrane suspensions (20-30 ug protein) were incubated with 
various concentrations of [3H]5-HT ranging from 0.16 to 30 nM in a 
total volume of 0.25 ml. Competition binding assays with agonist or 
antagonist were conducted using [3H]5-HT (3.0 nM) and [125I]LSD 
(20 pM) with concentrations of unlabelled ligands which varied from 
1 U.M to 0.1 pM. All reactions were performed in triplicate and the 
binding data were analyzed by non-linear least-squares regression us-
ing the computer program LIGAND [15]. 
2.4. Adenylyl cylase assays 
Cell membranes were prepared from virus-infected Sf9 cells at 48 hpi 
as described [14] and used to determine adenylyl cyclase activities as 
detailed by [16]. Enzyme reactions were initiated by the addition of 
prepared membranes (30^0 u.g protein) to reaction mixes in the ab-
sence or presence of various concentrations of 5-HT. Reactions were 
performed in triplicate and data were calculated as picomoles of 
cAMP produced per minute per milligram of membrane protein and 
analysed using non-linear least-squares regression with the aid of the 
computer program GraphPad Prism (San Diego, CA). 
20 
[3H]5-HT(nM) 
30 
3. Results and discussion 
Using the plasmid p514/5-HT7 as template DNA, a 1355 bp 
fragment encoding the mouse 5-HT7 receptor was amplified 
by PCR and cloned into the baculovirus transfer vector pA-
cAL3. This step was essential in order to remove a potential 
ATG translation start site from the 5' non-coding region of 
the 5-HT7 cDNA. A recombinant baculovirus (Ac5HT7) was 
subsequently constructed in which the 1355 bp DNA fragment 
was placed under control of the highly efficient polyhedrin 
promoter. To assess the levels of receptor expression, satura-
tion experiments were performed using membranes prepared 
from Ac5HT7-infected Sf9 cells harvested at 48 hpi. Fig. 1A 
shows that the binding of [3H]5-HT was saturable and non-
linear regression analysis of this binding data revealed the 
existence of a single class of receptor binding site with an 
affinity constant (Ki) of 3.93 nM (±0.46, « = 4), and 
#max = 24.3 (±5.2) pmol/mg of membrane protein. A major 
characteristic of the 5-HT7 receptor subtype is that it displays 
high affinity for the 5-HTi agonist, 5-CT. In this study, bind-
ing of [3H]5-HT was shown to be displaced with high affinity 
by 5-CT (IC50 1.3 ±0.04 nM, Fig. IB), and in addition by the 
non-selective 5-HT receptor antagonist methysergide (IC50 
18.0 ± 1.0 nM, Fig. IB). As expected, these data were in agree-
ment with previous studies [4] and indicated that the mouse 
5-HT7 receptor molecule synthesized in insect cells exhibited 
ligand binding properties similar to those observed in the 
mammalian COS-7 cell expression system. However, levels 
of 5-HT7 receptor expression in insect cells were observed to 
be higher (=; 3.5-fold) than previously reported [4] thus high-
lighting one of the advantages of the baculovirus expression 
system. Further characterisation of the 5-HT7 receptor in-
volved confirmation that the receptor would stimulate adenyl-
yl cyclase via the stimulatory G-protein, Gocs. As shown in 
Fig. 3, adenylyl cyclase activity was found to increase in a 
dose-dependent manner (EC50 48.0 ± 1.2 nM, Fig. 3) in mem-
branes prepared from Ac5HT7-infected Sf9 cells and incu-
bated with various concentrations of 5-HT. This stimulation 
was also inhibited in a dose-dependent manner by methiothe-
pin (75.0 ±0.8 nM, data not shown). 
Once functional 5-HT7 receptor synthesis in Sf9 insect cells 
had been established, we undertook a mutagenic study to 
define receptor domains responsible for the productive cou-
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Fig. 1. A: Saturation binding curve of [3H]5-HT to membranes pre-
pared from Ac5-HT7 (WT) infected Sf9 cells. Data are the mean of 
triplicate determinations from a single experiment typical of four in-
dependent experiments. B: Displacement of [3H]5-HT binding to 
membranes prepared from Ac5-HT7 (WT) infected Sf9 cells. The 
binding of 3 nM [3H]5-HT to membranes was performed in the 
presence of 5-CT (■) or methiothepin (•). Data are representative 
of two independent experiments with each point measured in tripli-
cate. 
pling to the stimulatory G-protein (Gocs). Various studies on 
the p2-AR and other receptors that couple to Ga s [1,2] sug-
gest that binding of the agonist induces a conformational 
change in the receptor molecule which allows the intracellular 
portions of the receptor to interact with the G-protein. This 
evidence has implicated the second and third intracellular 
loops as well as the C-terminal tail of the p-AR as all playing 
some role in receptor-G-protein coupling [2]. The deletion of 
small segments of amino acids from the N- and C-terminal 
portions of the third intracellular loops demonstrated the con-
tribution of these domains to p2-AR-mediated activation of 
adenylyl cyclase [2]. 
Mutant mouse 5-HT7 receptors were generated in which 
amino acid substitutions or deletions were made in N- and 
C-terminal portions of the third intracellular loop as well as 
the second intracellular loop. In this study we focused on the 
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role of charged amino acid residues found in these receptor 
domains and substituted these amino acids for neutral alanine 
or serine residues in order to determine if the high proportion 
of charged amino acids were required for productive coupling 
to Gas. Previous studies by [17] suggested that for the ham-
ster (32-AR charged amino acids in the N-terminal region of 
the third-intracellular loop were less critical for receptor-
G-protein interaction than hydrophobic residues. It was thus 
of interest to establish the relevance of this observation in 
relation to the mouse 5-HT7 receptor. In all cases the 
DNAs encoding the mutant mouse 5-HT7 receptors were veri-
fied by double-stranded DNA sequencing, to ensure both the 
presence of the mutation but also to confirm that additional 
mutations had not been produced. Recombinant baculovi-
ruses encoding the various mutant receptor proteins were pro-
duced and subsequently expressed in Sf9 insect cells. Recep-
tors with mutations in the N-terminal portion of the third 
intracellular loop were designated 5-HT7(K267A), 5-HT7-
(K267A,R270A,K271A) and 5-HT7(A263-275). Those recep-
tors with mutations the C-terminus of this loop were referred 
to as 5-HT7(E325G) and 5-HT7(K327S). While a receptor 
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Fig. 2. A: Specific binding of 0.1 nM [125I]LSD to wild-type 
and mutant 5-HT7 receptors expressed in SB cells (data are 
mean±SEM, » = 3). B: Competition binding of wild-type and mu-
tant receptors. Competition binding of methiothepin with [125I]LSD 
(20 pM) to membranes prepared from Sf9 cells expressing 
5-HT7(WT) (o), 5-HT7(K327S) (■), 5-HT7(E325G) (•) and 5-HT7-
(R183A) (0) receptors. 
B 
e 
g 
a. 
log [5-HT] (M ) 
Fig. 3. Stimulation by 5-HT of adenylyl cyclase in Sf9 cells express-
ing wild-type and mutant 5-HT7 receptors. Adenylyl cyclase activity 
was measured in the presence of 5-HT in membranes derived from 
Sf9 cells infected with the recombinant baculoviruses Ac5HT7(WT) 
(O), Ac5HT7 (E325G) (•) and Ac5HT7(K327S) (■). Data are the 
mean ± SEM of 2-3 independent experiments with each point deter-
mined in triplicate. 
with a single point mutation in the second intracellular loop 
was designated 5-HT7(R183A). 
Ligand binding experiments using [125I]LSD were initially 
undertaken to evaluate the effects of the mutations on the 
overall levels of receptor expression in insect cells (Fig. 2A). 
The deletion of 13 amino acids in the mutant 5HT7(A263-275) 
caused a reduction in [125I]LSD binding capability presumably 
due to structural constraints introduced by this deletion. Sim-
ilarly, the receptor mutant 5-HT7(K267A), and the triple mu-
tant 5-HT7(K267A,R270A,K271A), showed marked reduc-
tions in ability to support ligand binding also suggesting 
incorrect folding or membrane insertion of the receptors in 
the plasma membrane. For this reason the signalling proper-
ties of these mutant receptors were not studied. Of interest is 
the mutant receptor 5-HT7(R183A) in which the invariant 
arginine (R183) residue in the DRY sequence motif was sub-
stituted for alanine. This motif which is found in a large 
number G-protein-coupled receptors is thought to be impor-
tant for receptor-G-protein coupling [11,12]. Substitution of 
this invariant arginine has previously been reported to result 
in loss of coupling to Gas in the case of the VP2 vasopressin 
receptor [18] or Gaq for the aiB-adrenergic receptor [19]. In 
either case no concomitant loss in ligand binding was ob-
served. The mutant 5-HT7(R183A) was further characterized 
by an apparent increase in affinity for the antagonist methio-
thepin (IC50 1.9 ±0.06 nM, Fig. 2B) when compared to the 
wild-type receptor (IC50 6.2 ±0.03 nM). It would therefore 
appear that R183 is required for maintaining the structural 
integrity the mouse 5-HT7 receptor. 
On the strength that the receptor mutants 5-HT7(E325G) 
and 5-HT7(K327S) appeared to be correctly processed and 
expressed (Fig. 2A), these receptor species were further char-
acterized. When the 5-HT receptor antagonist methiothe-
pin was used to compete for [125I]LSD binding, the 5-
HT7(E325G) and 5-HT7(K327S) receptors displayed similar 
affinities (IC50 of 8.0 ±0.03 and 5.7 nM, respectively) to 
that of the wild-type receptor (IC50 6.2 ±0.03 nM). In addi-
tion, saturation experiments using the radiolabeled agonist 
[3H]5-HT, revealed no significant changes (P < 0.05) in affinity 
for this ligand. The apparent K& values were as follows; 
5-HT7(E325G): 3.9 ±0.6 nM (« = 3), 5-HT7(K327S), 
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K4 5.3 ±0.4 nM (n = 3) receptors. Furthermore, no significant 
changes in Bmax values were obtained. 
Given that there were no apparent changes in the phar-
macological binding properties of the 5-HT7(E325G) and 
5-HT7(K327A) the abilities of these mutants to modulate 
adenylyl cyclase activity in the presence of 5-HT were inves-
tigated. As shown in Fig. 3, both mutant receptors exhibited 
significantly impaired ( > 50%) abilities to stimulate adenylyl 
cyclase (Fig. 3) implying a critical role of residues E325 and 
K327 in receptor-G-protein interaction. The EC50 for the 
mutant receptor 5-HT7(E325G) was 10.0 ±0.2 nM while 
that for the mutant 5-HT7(K327A) receptor could not be 
reliably determined due to the lack of a suitable inflection 
point for the 5-HT-induced adenylyl cyclase activity. 
Our results have identified two amino acids residues which 
are important for coupling of the mouse 5-HT7 receptor to 
Gas proteins. Substitution of E325 for G or K327 for S in the 
receptor mutants 5-HT7(E325G) and 5-HT7(K327S) respec-
tively, impaired receptor-G-protein coupling as inferred 
from the reduction in ability to stimulate adenylyl cyclase. 
In either case these amino acid substitutions were not associ-
ated with any changes in the agonist binding properties of the 
receptor. The presented data are in agreement with the view 
that the C-terminal region of the third intracellular loop of 
G-protein-coupled receptors contains some of the information 
required for effective coupling. The specificity of these muta-
tions and the fact that charged residues E325 and K327 were 
substituted does signify that productive interaction of the 
mouse 5-HT7 receptor with Gas proteins may perhaps be 
governed by electrostatic interactions. However, the inability 
to completely abolish the 5-HT stimulated activation of ad-
enylyl cyclase indicates the requirement of additional residues 
or domains in this interaction. Previous studies [20] have im-
plied that the charged amino acid residues found in either the 
N- or C-terminal regions are unlikely to be the determinants 
of efficient receptor-G-protein coupling. In this respect our 
findings differ from these observations and could reflect a 
specific feature of 5-HT receptors that couple to Gas-
Finally, in addition to establishing if substitution of both 
residues E325 and K327 does abolish cAMP production we 
are currently investigating the role of other charged amino 
acids in C-terminal region in the third intracellular loop of 
the mouse 5-HT7 receptor. Although, the site-specific muta-
tions that were made in the N-terminal region of the third 
intracellular loop and the second intracellular loop resulted in 
an apparent loss of receptor function the present data cannot 
exclude the role of these domains in receptor-G-protein inter-
action. Taken together, however, our results demonstrate the 
requirement for maintenance of the structural integrity of all 
intracellular domains for productive coupling of the 5-HT7 
receptor with Gas. 
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